Hiroshima University PROSPECTUS 2024-2025
6/32

05Chief Executive, Pharmaceuticals andChief Executive, Pharmaceuticals andMedical Devices Agency (PMDA)Medical Devices Agency (PMDA)President, Hiroshima UniversityPresident, Hiroshima UniversityThe Pharmaceuticals and Medical Devices Agency (PMDA) is committed to ensuring a stable and prompt supply of pharmaceuticals and medical devices of the safest and most effective quality possible to healthcare professionals, thereby contributing to improving medical standards. Dr. Fujiwara, PMDAʼs Chief Executive, is a physician and a graduate of Hi-roshima University who has dedicated his medical career to research and practice in medical oncology for many years at the National Cancer Center. He sat down for a Special Talk with Hiroshima Universityʼs President Ochi, another physi-cian. The two discussed their student days, the problems facing Japanʼs medical community as viewed from PMDA, and various other topics.Dr. FUJIWARA YasuhiroFeature:SpecialTalkDr. OCHI MitsuoWhat university educationcan do for the futureof medicine

元のページ  ../index.html#6

このブックを見る